Now, for the administration itself
Keywords: GLP-1 receptor agonists, type 2 diabetes mellitus, obesity management, incretin hormones, molecular pharmacology Introduction The increasing global prevalence of type two diabetes mellitus (DM2) and obesity has brought them to the forefront of public health challenges
It helps the body convert carbohydrates, proteins, and fats into usable energy efficiently
In its standing guidance on unapproved GLP-1 drugs, the US FDA warned companies that have illegally sold unapproved drugs containing semaglutide, tirzepatide or retatrutide that are falsely labeled for research purposes or not for human consumption. The agency was specific that these products have been sold directly to consumers for human use with dosing instructions, which is to say the FDA understands perfectly well that the research only label is a fig leaf and has said so
Prices for each injection can be found here